Treatment for Adolescents with Depression Study (TADS): long-term efficacy and tolerability of fluoxetine and cognitive behavioural therapy (CBT), alone and in combination, in the treatment of adolescents with depression.

Trial Profile

Treatment for Adolescents with Depression Study (TADS): long-term efficacy and tolerability of fluoxetine and cognitive behavioural therapy (CBT), alone and in combination, in the treatment of adolescents with depression.

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Sep 2011

At a glance

  • Drugs Fluoxetine (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Acronyms TADS
  • Most Recent Events

    • 07 Sep 2011 Results of an analysis that focused on the effect of insomnia on treatment outcomes presented at the 24th Annual Congress of the European College of Neuropsychopharmacology.
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top